ARTICLE | Clinical News
Angiotech completes Phase II enrollment
March 1, 2001 8:00 AM UTC
Angiotech (ANPI; TSE:ANP) completed enrollment of a 189-patient Phase II study of micellar (liposomal) paclitaxel to treat secondary progressive multiple sclerosis. The primary objective of the double...